Please login to the form below

Not currently logged in
Email:
Password:

Roche buys mtm laboratories

Roche has completed the full acquisition of Germany-based mtm laboratories, a company specialising in products for cervical cancer diagnosis

Roche has completed the full acquisition of Germany-based mtm laboratories, a company specialising in products for cervical cancer diagnosis.

Roche will pay €130m upfront, with a further €60m available to mtm shareholders depending on performance-related milestones.

The transaction is expected to close in the coming weeks, with mtm to become part of Roche's tissue diagnostics unit, Ventana Medical Systems.

Commenting on the deal, Daniel O'Day, chief operating officer, Roche Diagnostics, said mtm's products are "highly complementary" to Roche's current 'cobas' diagnostic technologies for human papiloma virus (HPV) – a common cause of cervical cancer.

As part of the deal, Roche will acquire mtm's tools for diagnosis, including a test to measure levels of the p16 biomarker, with a significant increase associated with persistent HPV infection and the possibility of cancer development.

"The combination of cobas HPV and p16 tests may redefine the standard of care for cervical cancer testing by improving detection, reducing unnecessary cervical biopsies, and improving the confirmation of cervical pre-cancer," said O'Day.

19th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics